Novopharm challenges Diflucan patent
Executive Summary
Pfizer is evaluating a Waxman/Hatch notification from Novopharm challenging Pfizer's fluconazole patent (No. 4,404,216), Pfizer's recent 10-K filing states. Novopharm (now owned by Teva) has filed an ANDA for 50 mg, 100 mg, 150 mg and 200 mg tablets. The patent expires in January 2004